440 related articles for article (PubMed ID: 10096560)
1. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells.
Kramer DL; Vujcic S; Diegelman P; Alderfer J; Miller JT; Black JD; Bergeron RJ; Porter CW
Cancer Res; 1999 Mar; 59(6):1278-86. PubMed ID: 10096560
[TBL] [Abstract][Full Text] [Related]
2. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
4. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.
Kramer DL; Fogel-Petrovic M; Diegelman P; Cooley JM; Bernacki RJ; McManis JS; Bergeron RJ; Porter CW
Cancer Res; 1997 Dec; 57(24):5521-7. PubMed ID: 9407962
[TBL] [Abstract][Full Text] [Related]
6. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.
Porter CW; Ganis B; Libby PR; Bergeron RJ
Cancer Res; 1991 Jul; 51(14):3715-20. PubMed ID: 2065327
[TBL] [Abstract][Full Text] [Related]
7. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
8. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
Vaziri C; Stice L; Faller DV
Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
11. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
[TBL] [Abstract][Full Text] [Related]
14. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
Kim WH; Kang KH; Kim MY; Choi KH
Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
[TBL] [Abstract][Full Text] [Related]
15. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells.
Chen Y; Kramer DL; Li F; Porter CW
Oncogene; 2003 Aug; 22(32):4964-72. PubMed ID: 12902979
[TBL] [Abstract][Full Text] [Related]
16. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
Khanna KK; Beamish H; Yan J; Hobson K; Williams R; Dunn I; Lavin MF
Oncogene; 1995 Aug; 11(4):609-18. PubMed ID: 7651723
[TBL] [Abstract][Full Text] [Related]
17. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
18. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression.
Linke SP; Harris MP; Neugebauer SE; Clarkin KC; Shepard HM; Maneval DC; Wahl GM
Oncogene; 1997 Jul; 15(3):337-45. PubMed ID: 9233768
[TBL] [Abstract][Full Text] [Related]
19. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]